Compare & contrast JAL's Investor Presentation vs that of TIG's:http://www.jamesonresources.com.au/index.php/component/edocman/investor-presentation-may-2018/viewdocument?Itemid=
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution